Clinical trial · Observational
QoLiCOL - Quality of Life in Colon Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
All patients presenting at participating hospitals during the recruitment period with a newly diagnosed colon cancer, regardless of stage and planned treatment, will be eligible for inclusion. They will answer a questionnaire on health related quality of life, physical symptoms, functional impairments and socioeconomic status at diagnosis and after 12, 36 months. Clinical data including recurrence, survival, surgical treatment, oncologic result (pathology report) and adjuvant treatment will be collected from the Swedish ColoRectal Cancer Registry (SCRCR)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colonic Neoplasm | Colon Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| There is no intervention, only observation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with colon cancer
- description
- All patients presenting with a newly diagnosed colon cancer regardless of tumour stage
- interventionNames
- Behavioral: There is no intervention, only observation
Primary outcomes (1)
- measure
- QoL in colon cancer patients
- timeFrame
- 3 years
- description
- The primary end-point is to describe QoL, symptoms and functional impairments in an unselected population of colon cancer patients
Secondary outcomes (11)
- measure
- Generate basic descriptive data of the patient population, such as demography, socioeconomic data, disease stage at diagnosis, type of treatment, recurrence and survival
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Colon cancer newly diagnosed. * Planned treatment presented Exclusion Criteria: * No Colon cancer diagnosis, * below 18 years of age, * no informed consent or withdrawn informed consent.
References
Publications (2)
- DERIVEDSandberg SJ, Park JM, Tasselius VA, Angenete E. Bowel Dysfunction After Colon Cancer Surgery: A Prospective, Longitudinal, Multicenter Study. Dis Colon Rectum. 2024 Oct 1;67(10):1322-1331. doi: 10.1097/DCR.0000000000003358. Epub 2024 Jun 20. PMID 38902840
- DERIVEDEhrencrona C, Li Y, Angenete E, Haglind E, Franzen S, Grimby-Ekman A, Bock D. Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? - An emulated trial. BMC Cancer. 2024 Apr 11;24(1):447. doi: 10.1186/s12885-024-12236-3. PMID 38605350